Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 70, Issue 1, 2011, Pages 201-207

  Van Bavel, Casandra C ^a   Dieker, Jürgen W ^a   Kroeze, Yvet ^a   Tamboer, Wim P ^a   Voll, Reinhard ^b   Muller, Sylviane ^c   Berden, Jo H ^a   Van Der Vlag, Johan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; HISTONE DEMETHYLASE; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BT164; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CHROMATIN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTONE MODIFICATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; METHYLATION; MOUSE; NONHUMAN; NUCLEOSOME; PHAGE DISPLAY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; AUTOANTIBODIES; CHROMATIN; EPITOPE MAPPING; HISTONES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; METHYLATION; MICE; MICE, INBRED MRL LPR; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; TUMOR CELLS, CULTURED;

EID: 77957942335     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.129320     Document Type: Article

References (38)

1. van Bavel CC, van der Vlag J, Berden JH. Nucleosome-specific autoantibodies. In: Shoenfeld Y, Gershwin ME, Meroni PL, eds. Autoantibodies. 2nd edn. Amsterdam: Elsevier, 2007: 197 - 204.
2. Licht R, Dieker JW, Jacobs CW, et al. Decreased phagocytosis of apoptotic cells in diseased SLE mice. J Autoimmun 2004; 22 : 139-45.
3. Herrmann M, Voll RE, Zoller OM, et al. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41 : 1241-50.
4. Licht R, van Bruggen MC, Oppers-Walgreen B, et al. Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration. Arthritis Rheum 2001; 44 : 1320-30 .
5. Cheung WL, Ajiro K, Samejima K, et al. Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 2003; 113 : 507-17 .
6. Hurd PJ, Bannister AJ, Halls K, et al. Phosphorylation of histone H3 Thr-45 is linked to apoptosis. J Biol Chem 2009; 284 : 16575-83.
7. Cheng MF, Lee CH, Hsia KT, et al. Methylation of histone H3 lysine 27 associated with apoptosis in osteosarcoma cells induced by staurosporine. Histol Histopathol 2009; 24 : 1105-11.
8. Dieker JW, Fransen JH, van Bavel CC, et al. Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. Arthritis Rheum 2007; 56 : 1921-33.
9. van Bavel CC, Dieker J, Muller S, et al. Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies. Mol Immunol 2009; 47 : 511-16.
10. Rosen A, Casciola-Rosen L. Autoantigens in systemic autoimmunity: critical partner in pathogenesis. J Intern Med 2009; 265 : 625-31.
11. Fransen JH, Hilbrands LB, Ruben J, et al. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. Arthritis Rheum 2009; 60 : 2304-13.
12. Fransen JH, Hilbrands LB, Jacobs CW, et al. Both early and late apoptotic blebs are taken up by DC and induce IL-6 production. Autoimmunity 2009; 42 : 325-7.
13. Munoz LE, van Bavel C, Franz S, et al. Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus 2008; 17 : 371-5.
14. Guchhait P, Tosi MF, Smith CW, et al. The murine myeloid cell line 32Dcl3 as a model system for studying neutrophil functions. J Immunol Methods: 2003; 283 : 195-204.
15. van der Heijden GW, Dieker JW, Derijck AA, et al. Asymmetry in histone H3 variants and lysine methylation between paternal and maternal chromatin of the early mouse zygote. Mech Dev 2005; 122 : 1008-22.
16. Peters AH, Kubicek S, Mechtler K, et al. Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol Cell 2003; 12 : 1577-89.
17. van der Vlag J, Otte AP. Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nat Genet 1999; 23 : 474-8.
18. Dieker JW, Sun YJ, Jacobs CW, et al. Mimotopes for lupus-derived anti-DNA and nucleosome-specific autoantibodies selected from random peptide phage display libraries: facts and follies. J Immunol Methods: 2005; 296 : 83-93.
19. Agger K, Cloos PA, Christensen J, et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 2007; 449 : 731-4 .
20. De Santa F, Totaro MG, Prosperini E, et al. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 2007; 130 : 1083-94.
21. Lan F, Bayliss PE, Rinn JL, et al. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 2007; 449 : 689-94.
22. Lee M G, Villa R, Trojer P, et al. D emethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 2007; 318 : 447-50.
23. Chadwick BP, Willard HF. Multiple spatially distinct types of facultative heterochromatin on the human inactive X chromosome. Proc Natl Acad Sci USA 2004; 101 : 17450-5.
24. Plath K, Fang J, Mlynarczyk-Evans SK, et al. Role of histone H3 lysine 27 methylation in X inactivation. Science 2003; 300 : 131-5.
25. Kim SM, Kee HJ, Choe N, et al. The histone methyltransferase activity of WHISTLE is important for the induction of apoptosis and HDAC1-mediated transcriptional repression. Exp Cell Res 2007; 313 : 975-83.
26. Garcia BA, Busby SA, Shabanowitz J, et al. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition. J Proteome Res 2005; 4 : 2032-42.
27. Hu N, Qiu X, Luo Y, et al. Abnormal histone modification patterns in lupus CD4+ T cells. J Rheumatol 2008; 35 : 804-10.
28. Boix-Chornet M, Fraga MF, Villar-Garea A, et al. Release of hypoacetylated and trimethylated histone H4 is an epigenetic marker of early apoptosis. J Biol Chem 2006; 281 : 13540-7.
29. Muller S, Bonnier D, Thiry M, et al. Reactivity of autoantibodies in systemic lupus erythematosus with synthetic core histone peptides. Int Arch Allergy Appl Immunol 1989; 89 : 288-96.
30. Gohill J, Cary PD, Couppez M, et al. Antibodies from patients with drug-induced and idiopathic lupus erythematosus react with epitopes restricted to the amino and carboxyl termini of histone. J Immunol 1985; 135 : 3116-21.
31. Lu L, Kaliyaperumal A, Boumpas DT, et al. Major peptide autoepitopes for nucleosome-specific T cells of human lupus. J Clin Invest 1999; 104 : 345-55.
32. Fournel S, Neichel S, Dali H, et al. CD4+ T cells from (New Zealand Black × New Zealand White) F1 lupus mice and normal mice immunized against apoptotic nucleosomes recognize similar Th cell epitopes in the C terminus of histone H3. J Immunol 2003; 171 : 636-44.
33. Suen JL, Chuang YH, Tsai BY, et al. Treatment of murine lupus using nucleosomal T cell epitopes identified by bone marrow-derived dendritic cells. Arthritis Rheum 2004; 50 : 3250-9.
34. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179 : 1317-30.
35. Radic M, Marion T, Monestier M. Nucleosomes are exposed at the cell surface in apoptosis. J Immunol 2004; 172 : 6692-700.
36. van Bavel CC, Fenton KA, Rekvig OP, et al. Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus. Arthritis Rheum 2008; 58 : 1892 - 9.
37. Kaliyaperumal A, Michaels MA, Datta SK. Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells. J Immunol 1999; 162 : 5775-83.
38. Muller S, Monneaux F, Schall N, et al. Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial. Arthritis Rheum 2008; 58 : 3873-83.